Phreesia Inc. (PHR)
NYSE: PHRHealthcareHealth Information ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
PHR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $651.74M
- P/E (TTM)
- 61.76
- Forward P/E
- 6.64
- EPS (TTM)
- $0.17
- Dividend yield
- None
- 52-week range
- 7.77 – 24.25
- Day range
- 10.21 – 10.55
- Volume / Avg
- 595.88K / 743.85K
- Beta
- —
- Shares outstanding
- 62.07M
52-week range
PHR stock today
Phreesia (PHR) closed at $10.50 on Oct 7, up 2.44% (+$0.25), versus the S&P 500's 0.22% decline. At this level, PHR sits near the bottom of its 52-week range of $7.77 to $24.25: 56.7% below the high, set on Oct 9, 2025 and 35.1% above the low. PHR is down 37.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 55.1%.
Phreesia trades at 61.8x its trailing twelve-month earnings per share of $0.17. Its forward P/E of 6.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Phreesia
Company profilePhreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions.
- Sector
- Healthcare
- Industry
- Health Information Services
- CEO
- Mr. Chaim Indig
- Headquarters
- Wilmington, DE
- Employees
- 1,789
- IPO year
- 2019
- Website
- phreesia.com
Analyst forecast
ForecastConsensus (18 analysts)
buy
Avg. price target
$14.07+34.00%
- Strong buy 2
- Buy 8
- Hold 8
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Phreesia peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SOPHSOPHiA GENETICS SA | 7.15 | -3.12% | $608.66M | vs PHR |
| WEAVWeave Communications Inc. | 7.37 | -0.14% | $592.92M | vs PHR |
| EVHEvolent Health Inc Class A | 4.14 | +7.81% | $468.07M | vs PHR |
| NRCNRC Health | 20.19 | +0.55% | $446.59M | vs PHR |
| CTEVClaritev Corporation Class A | 25.03 | +3.90% | $424.20M | vs PHR |
| CARLCarlsmed Inc. | 14.38 | -1.78% | $392.61M | vs PHR |
| HSTMHealthStream Inc. | 32.10 | +2.52% | $982.13M | vs PHR |
| TDOCTeladoc Health Inc. | 5.56 | -3.64% | $1.01B | vs PHR |
Indexes, lists and sector
Appears in lists
Phreesia stock FAQ
What is Phreesia's stock price today?
PHR last traded at $10.50 as of Oct 7, 4:00 PM EDT, up 2.44% on the day. Prices are delayed at least 15 minutes.
What is PHR's P/E ratio?
PHR trades at a trailing P/E ratio of 61.76 and a forward P/E of 6.64.
Who is Phreesia's CEO?
Mr. Chaim Indig is the chief executive officer of Phreesia Inc., which has about 1,789 employees.
What is the PHR 52-week high?
The 52-week high for PHR is $24.25 and the 52-week low is $7.77. The stock is currently 56.7% below its high.